These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38576821)

  • 1. Immunoglobulin A glomerulonephropathy: A review.
    El Labban M; Surani S
    World J Clin Cases; 2024 Mar; 12(8):1388-1394. PubMed ID: 38576821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of IgA Nephropathy: A Global Perspective.
    Schena FP; Nistor I
    Semin Nephrol; 2018 Sep; 38(5):435-442. PubMed ID: 30177015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic neutropenia and concomitant IgA nephropathy: a case report.
    Kapogiannis C; Zaggogianni T; Stergiou N; Kakleas K; Kapogiannis A; Gakiopoulou H; Kanaka-Gantenbein C
    BMC Nephrol; 2023 May; 24(1):124. PubMed ID: 37138249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade.
    Chen J; Liu S; Xu H; Wang W; Xie Y; Tang W; Yuan Q; Zheng L; Lin L; Fu S; Shen J
    Med Sci Monit; 2020 Aug; 26():e922839. PubMed ID: 32822333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
    Cagnoli L;
    G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glomerulonephritis and vasculitis as causes of arterial hypertension].
    Eicken S; Gugger M; Marti HP
    Ther Umsch; 2012 May; 69(5):283-94. PubMed ID: 22547360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria.
    Hoshino Y; Kaga T; Abe Y; Endo M; Wakai S; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M; Li W; Zou G; Zhang C; Fang J
    Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-immunosuppressive therapies for childhood IgA nephropathy.
    Shima Y; Nakanishi K; Yoshikawa N
    Pediatr Nephrol; 2021 Oct; 36(10):3057-3065. PubMed ID: 33594462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
    ; Jiang XY
    Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of IgA nephropathy: an update.
    Rosselli JL; Thacker SM; Karpinski JP; Petkewicz KA
    Ann Pharmacother; 2011 Oct; 45(10):1284-96. PubMed ID: 21954446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Treatment of IgA Nephropathy.
    Lai KN; Leung JC; Tang SC
    Kidney Dis (Basel); 2015 May; 1(1):19-26. PubMed ID: 27536661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
    Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of IgA nephropathy.
    Barratt J; Feehally J
    Kidney Int; 2006 Jun; 69(11):1934-8. PubMed ID: 16641928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
    Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
    Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hematuria on the kidney disease progression in IgA nephropathy patients with mild proteinuria and well-preserved renal function.
    Liu Y; Chen H; Wang H; Li Z; Li H; Wang F; Jia J; Li D; Yan T
    Int Immunopharmacol; 2023 Sep; 122():110635. PubMed ID: 37453157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M; Turczyn A; Such A; Cichoń-Kawa K; Małdyk J; Miklaszewska M; Pietrzyk J; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Szczepańska M; Bieniaś B; Zajączkowska M; Pukajło-Marczyk A; Zwolińska D; Siniewicz-Luzeńczyk K; Tkaczyk M; Gadomska-Prokop K; Grenda R; Demkow U; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2016; 952():75-84. PubMed ID: 27573641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.